SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-19-005914
Filing Date
2019-06-10
Accepted
2019-06-10 07:18:36
Documents
3
Period of Report
2019-06-10
Items
Item 1.03: Bankruptcy or Receivership
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20190609.htm 8-K 43825
2 EX-99.1 insy-ex991_14.htm EX-99 13858
3 GRAPHIC gjplfzabr3cj000001.jpg GRAPHIC 1994
  Complete submission text file 0000950123-19-005914.txt   61751
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 19887544
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1